Growth Metrics

Cryoport (CYRX) Asset Writedowns and Impairment (2016 - 2024)

Cryoport has reported Asset Writedowns and Impairment over the past 10 years, most recently at $63.8 million for Q2 2024.

  • Quarterly Asset Writedowns and Impairment changed N/A to $63.8 million in Q2 2024 from the year-ago period, while the trailing twelve-month figure was $64.0 million through Dec 2024, changed N/A year-over-year, with the annual reading at $63.8 million for FY2024, 28.73% up from the prior year.
  • Asset Writedowns and Impairment was $63.8 million for Q2 2024 at Cryoport, up from $221000.0 in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $63.8 million in Q2 2024 and troughed at -$237000.0 in Q4 2021.
  • The 4-year median for Asset Writedowns and Impairment is $31000.0 (2022), against an average of $4.9 million.
  • Year-over-year, Asset Writedowns and Impairment soared 156570.59% in 2020 and then tumbled 278.2% in 2021.
  • A 4-year view of Asset Writedowns and Impairment shows it stood at $133000.0 in 2020, then tumbled by 278.2% to -$237000.0 in 2021, then surged by 193.25% to $221000.0 in 2022, then surged by 28772.85% to $63.8 million in 2024.
  • Per Business Quant, the three most recent readings for CYRX's Asset Writedowns and Impairment are $63.8 million (Q2 2024), $221000.0 (Q4 2022), and -$22000.0 (Q3 2022).